In December, we added 97 citations in DIDB, including 43 in vitro (with 25 articles published in December 2025) and 54 in vivo articles (with 30 articles published in December 2025).
3 NDAs approved by the FDA in September and October 2025, including nerandomilast (JASCAYD), and paltusotine (PALSONIFY), remibrutinib (RHAPSIDO) were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.